BARI, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 1.922
EU - Europa 889
AS - Asia 627
AF - Africa 4
OC - Oceania 4
SA - Sud America 2
Totale 3.448
Nazione #
US - Stati Uniti d'America 1.887
CN - Cina 542
IE - Irlanda 491
IT - Italia 166
DE - Germania 87
SG - Singapore 65
FI - Finlandia 64
CA - Canada 35
SE - Svezia 26
FR - Francia 19
BE - Belgio 16
GB - Regno Unito 8
BD - Bangladesh 5
IN - India 4
JP - Giappone 4
MU - Mauritius 4
NL - Olanda 4
AU - Australia 3
RU - Federazione Russa 3
BR - Brasile 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
TH - Thailandia 2
CH - Svizzera 1
ES - Italia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 3.448
Città #
Chandler 528
Dublin 485
Ashburn 236
Nanjing 125
Boardman 95
Princeton 89
Lawrence 88
Medford 87
Beijing 77
Shanghai 66
Wilmington 64
Helsinki 61
New York 60
Ann Arbor 54
Pavia 53
Nanchang 42
Singapore 41
Dearborn 36
Shenyang 36
Hebei 34
Toronto 34
Changsha 32
Hangzhou 30
Jiaxing 30
Washington 27
Jacksonville 21
Piemonte 16
Brussels 14
Redwood City 14
Tianjin 14
Los Angeles 13
Dallas 11
Norwalk 10
Kunming 8
Woodbridge 8
Chicago 7
Fairfield 7
Munich 7
Xian 7
Des Moines 6
Frankfurt am Main 6
San Mateo 6
Travaco Siccomario 6
Berlin 5
Cambridge 5
Dhaka 5
Hefei 5
Houston 5
Ningbo 5
Rome 5
Cagliari 4
Esslingen am Neckar 4
Jinan 4
Milan 4
Padova 4
Tokyo 4
Brescia 3
Chengdu 3
Falkenstein 3
Guangzhou 3
Orange 3
Piscataway 3
Zhengzhou 3
Adelaide 2
Borås 2
Brno 2
Böblingen 2
Cedar Knolls 2
Clifton 2
Como 2
Cornigliano 2
Gent 2
Guidonia 2
Leawood 2
Legnano 2
Mantova 2
Naples 2
Phoenix 2
Redmond 2
Rockville 2
Seattle 2
Sovizzo 2
Stockholm 2
Taizhou 2
Terracina 2
Turin 2
West Jordan 2
Wuhan 2
Yonkers 2
Abbiategrasso 1
Andover 1
Ardabil 1
Auckland 1
Ban Nong Sala 1
Bangkok 1
Buccinasco 1
Chiasso 1
College Park 1
Farra di Soligo 1
Fuzhou 1
Totale 2.834
Nome #
Lyosecretome for use in the treatment of autoimmune diseases 84
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 83
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 74
Silk sericin and platelet lysate for intervertebral disc cell culture 68
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 63
Processo per isolare e liofilizzare vescicole extracellulari 62
Combining Inulin and Cyclodextrin for colon drug release 60
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 59
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthrit 58
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 57
3D Bioprinted Scaffolds Containing Mesenchymal Stem/Stromal Lyosecretome: Next Generation Controlled Release Device for Bone Regenerative Medicine 57
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 55
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 55
Equine freeze-dried secretome for joint regeneration in veterinary medicine: production process and in vitro efficacy 54
Controlled release of celecoxib from inulin based micelles 53
Cross-linked silk sericin microparticles as bioactive delivery system: formulation and in vitro cytotoxicity 53
Freeze-dried pharmaceutical formulations containing mesenchymal exosomes for acellular MSC immunomodulant therapy 53
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: in vitro efficacy in an osteoarthritis model 52
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 52
Sericin microparticles as bioactive carriers for local drug delivery: in vitro cytocompatibility profile 51
Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles 51
Isolation and characterization of B. mori silk sericin for topical applications 50
Canine mesenchymal Lyosecretome production and clinical use in osteoarthritic dogs. 50
Canine lyo-secretome for osteoarticular regeneration in veterinary medicine: pilot-production and in vitro efficacy 48
Efficacy of a freeze-dried product based on MSC-secretome (Lyosecretome) in a wound healing murine model. 47
Characterization and antioxidant activity of essential oil of four sympatric orchid species 47
In vitro cytotoxicity and potency of freeze-dried MSC-secretome (Lyosecretome). 46
Association of silk sericin and platelet lysate: Premises for the formulation of wound healing active medications 46
Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use 46
3D Bioprinted Scaffolds for controlled release of Mesenchymal Stem/Stromal Lyo-secretome in Bone Regeneration 46
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: in vitro cytotoxicity and potency 45
Human engineered cartilage and decellularized matrix as an alternative to animal osteoarthritis model 45
Nanoparticles for use in the redirection against the tumour of a non-tumour-specific immune response, based on a pre-existing immunity 44
Freeze-dried MSC-secretome (Lyosecretome) for regenerative medicine applications: pharmaceutical development. 43
Freeze-dried and GMP-compliant pharmaceuticals containing mesenchymal exosomes for acellular MSC immunomodulant therapy 43
Synthesis of differently bioconjugated novel c-RGD antagonist 43
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 43
In vitro efficacy of platelet lysate in association with silk sericin for intervertebral disk regeneration 42
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 42
Production, characterization, and in vitro efficacy of canine and equine lyo-secretome injectable formulation in regenerative medicine 41
Technological Development of Freeze-dried Mesenchymal Stem Cell Secretome Formulations 40
Freeze-dried secretome from mesenchymal stromal cells: a phase I clinical trial for equine and canine musculoskeletal diseases 40
Osteoinductive and osteoconductive properties of 3D Printed scaffolds containing Mesenchymal Stem/Stromal Lyosecretome 40
Canine mesenchymal stem cell lyo-secretome: in vitro potency evaluation and in vivo preliminary application in dogs with naturally occurring osteoarthritis 39
Auricchio F, Bari E, Conti M, Perteghella S, Scocozza F, Sorlini M, Torre ML. Scaffold per la rigenerazione tissutale, in particolare per la rigenerazione ossea, e relativo metodo di fabbricazione. 39
Pharmaceutical development of freeze-dried extracellular vesicles. 38
Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy 38
Production, characterization, and in vitro efficacy of a canine lyo-secretome injectable formulation for osteoarticular regeneration 38
From Bench to Bedside: The Long Way Towards GMP Scale-up, Preclinical and Clinical Trials for Silk-based Drug Delivery Systems 38
Efficacy of sponge-like dressing containing MSC lyo-secretome in a wound healing murine model 37
Chromatographic profiling of silk sericin for biomedical and cosmetic use by complementary hydrophylic, reversed phase and size exclusion chromatographic methods 37
Stem cell-extracellular vesicles loading silk/curcumin nanoparticles for drug delivery 36
Sponge-like formulations containing MSC lyo-secretome: efficacy in a wound healing murine model 36
Silk Fibroin Nanoparticle Functionalized with Arg-Gly-Asp cyclopentapeptide: Tumor specific Active Targeting 36
Silk sericin: from textile waste material to dermatological and cosmetic applications 36
From mesenchymal stem/stromal cells to cell products: pharmaceutical evelompment of secretome as new biological medicinal product 35
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery 35
Silk Fibroin Nanoparticle to Redirected Immunity Against Cancer 35
Osteoinductive and osteoconductive properties of titanium cages containing Mesenchymal Stem/Stromal Lyosecretome. 35
Osteoinductive and osteoconductive properties of Biohybrid Bovine Bone Matrix containing Mesenchymal Stem/Stromal Cell Lyosecretome 34
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: efficacy in a murine model of wound healing 33
Preparation and characterization of polyphenols-loaded silk sericin self-assembling nanosystems 33
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 32
Pilot production of mesenchymal stem/stromal freeze-dried secretome for cell-free regenerative nanomedicine: a validated GMP-compliant process. 31
Alternative culture media and cold-drying for obtaining high biological value Arthrospira platensis (Cyanobacteria) 31
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine 30
Silk-fibroin Micro-drug Delivery Systems 30
Silk 30
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 30
Silk-sericin Nano-drug Delivery Systems 29
Polyphenols-Loaded Sericin Self-Assembling Nanoparticles: A Slow-Release for Regeneration by Tissue-Resident Mesenchymal Stem/Stromal Cells 28
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 28
Silk-fibroin Nano-drug Delivery Systems 27
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 26
Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier? 26
Scaffold per la rigenerazione ossea e relativo metodo di fabbricazione 26
Pharmaceutical development of mesenchymal extracellular vescicle formulations 25
Silk fibroin nanoparticles to redirect immunity against different cancers: proof of concept in a murine model. 23
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide Derivative 22
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 22
Extracellular vesicles for lung regeneration in alpha-1-antitrypsin deficiency 21
Silk-sericin Micro-drug Delivery Systems 21
A new human platelet lysate for mesenchymal stem cell production compliant with Good Manufacturing Practice conditions preserve chemical characteristics and biological activity of lyo-secretome isolated by ultrafiltration 21
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 19
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 19
Silk-based Drug Delivery Systems 19
Growth Factors Delivery System for Skin Regeneration: An Advanced Wound Dressing 13
GMP-compliant sponge like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 13
GMP-compliant sponge-like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 11
Prediction of the mechanical response of a 3D (bio)printed hybrid scaffold for improving bone tissue regeneration by structural finite element analysis 2
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 2
Totale 3.576
Categoria #
all - tutte 17.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020146 0 0 0 0 7 9 24 32 20 27 23 4
2020/2021150 2 3 5 11 21 9 13 31 13 14 13 15
2021/2022483 1 3 51 10 4 20 6 31 24 5 97 231
2022/20231.372 188 111 27 94 93 141 4 63 591 7 26 27
2023/2024621 68 96 31 37 48 190 58 36 3 19 23 12
2024/2025248 29 103 42 36 38 0 0 0 0 0 0 0
Totale 3.576